RE: Sick CONTROL..... There is no enthusiasm left with retail holders. Bioniche has been one prolonged, torturous disappointment for most.
If there is any new interest out of the US, I suspect that there will be millions of shares available 20 or 30 cents North of here. There will be a wholesale turnover of the retail float at those levels, and maybe it is needed for everyone involved...Management and the retail guy. There is far too much acrimony between those in the know and the schleps who bought the company in good faith.
I am still betting on 4 consecutive RED closes though. I am still unclear as to why you would bother with any broker presentations until they had something concrete to discuss... "We withdrew from our P3B trial and dissolved our Endo partnership" is the sum total of the corporate highlights of the last year.
I cannot see how that can be spun as a positive to US clients.